Multisequence MRI-based radiomics nomogram for early prediction of osimertinib resistance in patients with non-small cell lung cancer brain metastases

BACKGROUND: Osimertinib resistance is a major problem in the course of targeted therapy for non-small cell lung cancer (NSCLC) patients. To develop and validate a multisequence MRI-based radiomics nomogram for early prediction of osimertinib resistance in NSCLC with brain metastases (BM). METHODS: P...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Xinna, Li, Ye, Xu, Xiaoyue, Zheng, Ziwei, Li, Fang, Fang, Kun, Wang, Yue, Wang, Bing, Hou, Dailun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485591/
https://www.ncbi.nlm.nih.gov/pubmed/37692549
http://dx.doi.org/10.1016/j.ejro.2023.100521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485591/
https://www.ncbi.nlm.nih.gov/pubmed/37692549
http://dx.doi.org/10.1016/j.ejro.2023.100521

Ejemplares similares